Hypertension

 
Daily Dose: ASCVD Risk Reduced by 10% with Diet
December 02, 2022

Your daily dose of clinical news you may have missed.

ASCVD Risk Reduced by 10% with Diet, Greater Drops Seen in Women, Black Adults
December 01, 2022

The therapeutic impact of the dietary lifestyle intervention and the differential effects could have major implications for clinical care and policy, say study authors.

Study: Surprising Number of Postpartum Hypertension Cases Occurred More than 6 Weeks After Birth
November 16, 2022

Analysis of women who did not have high blood pressure while pregnant found that 1 in 10 were diagnosed with hypertension in the year after delivery.

Daily Dose: Remote Hypertension and Lipid Program
November 14, 2022

Your daily dose of clinical news you may have missed.

Baxdrostat in Phase 2 Clinical Trial Proves Effective, Safe in Treatment-resistant Hypertension
November 14, 2022

Baxdrostat shows potential to represent the first new class of antihypertensive agents approved since 2017.

Fully Remote Intervention for Hypertension, Lipids Proves Feasible, Successful in Large, Diverse Health Care Network
November 11, 2022

The Mass General Brigham clinical intervention and study included 10 000 participants and resulted in significant reductions in SBP/DBP and LDL-C.

Early Months of COVID-19 Associated with Worsening BP Outcomes in Adults with Hypertension, New Study Finds
November 01, 2022

Use of telemedicine and home blood pressure monitoring may mitigate adverse impact on BP control during future large-scale emergencies, noted researchers.

4 New Drugs Approved for Primary Care: Q3 2022
October 06, 2022

Novel NMDA receptor antagonist approved for the treatment of major depressive disorder, first topical PDE4i approved for plaque psoriasis, and more.

FDA Recall Announced for Atenolol, Clopidogrel based on Labeling Mix-up
September 30, 2022

Only 1 lot of each medication was affected by the mislabeling, according to generic repackaging and distribution services company Golden State Medical Supply.

Dementia Risk May be Driven by Multimorbidity vs Single Risk Factors, Suggests a New Study
September 28, 2022

Multimorbidity was associated with a 63% increased risk for dementia among adults older than age 60 years followed for up to 15 years.